Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2021 | 1 |
2022 | 1 |
2023 | 3 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Peptide-conjugated antimiRs improve myotonic dystrophy type 1 phenotypes by promoting endogenous MBNL1 expression.
Mol Ther Nucleic Acids. 2023 Sep 5;34:102024. doi: 10.1016/j.omtn.2023.09.001. eCollection 2023 Dec 12.
Mol Ther Nucleic Acids. 2023.
PMID: 37744174
Free PMC article.
Deciphering the Complex Molecular Pathogenesis of Myotonic Dystrophy Type 1 through Omics Studies.
Espinosa-Espinosa J, González-Barriga A, López-Castel A, Artero R.
Espinosa-Espinosa J, et al.
Int J Mol Sci. 2022 Jan 27;23(3):1441. doi: 10.3390/ijms23031441.
Int J Mol Sci. 2022.
PMID: 35163365
Free PMC article.
Review.
Item in Clipboard
BlockmiR AONs as Site-Specific Therapeutic MBNL Modulation in Myotonic Dystrophy 2D and 3D Muscle Cells and HSALR Mice.
Overby SJ, Cerro-Herreros E, Espinosa-Espinosa J, González-Martínez I, Moreno N, Fernández-Costa JM, Balaguer-Trias J, Ramón-Azcón J, Pérez-Alonso M, Møller T, Llamusí B, Artero R.
Overby SJ, et al. Among authors: espinosa espinosa j.
Pharmaceutics. 2023 Mar 31;15(4):1118. doi: 10.3390/pharmaceutics15041118.
Pharmaceutics. 2023.
PMID: 37111604
Free PMC article.
Item in Clipboard
CRISPR-Cas9 editing of a TNPO3 mutation in a muscle cell model of limb-girdle muscular dystrophy type D2.
Poyatos-García J, Blázquez-Bernal Á, Selva-Giménez M, Bargiela A, Espinosa-Espinosa J, Vázquez-Manrique RP, Bigot A, Artero R, Vilchez JJ.
Poyatos-García J, et al. Among authors: espinosa espinosa j.
Mol Ther Nucleic Acids. 2023 Jan 11;31:324-338. doi: 10.1016/j.omtn.2023.01.004. eCollection 2023 Mar 14.
Mol Ther Nucleic Acids. 2023.
PMID: 36789274
Free PMC article.
Item in Clipboard
Increased Muscleblind levels by chloroquine treatment improve myotonic dystrophy type 1 phenotypes in in vitro and in vivo models.
Bargiela A, Sabater-Arcis M, Espinosa-Espinosa J, Zulaica M, Lopez de Munain A, Artero R.
Bargiela A, et al. Among authors: espinosa espinosa j.
Proc Natl Acad Sci U S A. 2019 Dec 10;116(50):25203-25213. doi: 10.1073/pnas.1820297116. Epub 2019 Nov 21.
Proc Natl Acad Sci U S A. 2019.
PMID: 31754023
Free PMC article.
Item in Clipboard
Preclinical characterization of antagomiR-218 as a potential treatment for myotonic dystrophy.
Cerro-Herreros E, González-Martínez I, Moreno N, Espinosa-Espinosa J, Fernández-Costa JM, Colom-Rodrigo A, Overby SJ, Seoane-Miraz D, Poyatos-García J, Vilchez JJ, López de Munain A, Varela MA, Wood MJ, Pérez-Alonso M, Llamusí B, Artero R.
Cerro-Herreros E, et al. Among authors: espinosa espinosa j.
Mol Ther Nucleic Acids. 2021 Jul 29;26:174-191. doi: 10.1016/j.omtn.2021.07.017. eCollection 2021 Dec 3.
Mol Ther Nucleic Acids. 2021.
PMID: 34513303
Free PMC article.
Item in Clipboard
Cite
Cite